ERK1/2 MAPKs and Wnt signaling pathways are independently involved in adipocytokine-mediated aldosterone secretion

Experimental and Clinical Endocrinology and Diabetes

Volumn 119, Issue 10, 2011, Pages 644-648

  Vleugels, K ^a   Schinner, S ^b   Krause, D ^b   Morawietz, H ^a   Bornstein, S R ^a   Ehrhart Bornstein, M ^c   Krug, A W ^c  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

adipocytokines; adrenal cortex; aldosterone; ERK1 2 MAPK; hypertension; obesity; Wnt

Indexed keywords

ADIPOCYTOKINE; ALDOSTERONE; BETA CATENIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; REGULATOR PROTEIN; STEROID ACUTE REGULATORY PROTEIN; STEROIDOGENIC FACTOR 1; UNCLASSIFIED DRUG; WNT PROTEIN;

ADULT; ARTICLE; BINDING SITE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN STRUCTURE;

ADIPOCYTES; ADIPOKINES; ADRENAL CORTEX; ALDOSTERONE; BETA CATENIN; CELL COMMUNICATION; CELL LINE; CELLS, CULTURED; FEMALE; GENES, REPORTER; HUMANS; MAP KINASE SIGNALING SYSTEM; MUTANT PROTEINS; OVERWEIGHT; PHOSPHOPROTEINS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT PROTEINS; STEROIDOGENIC FACTOR 1; SUBCUTANEOUS FAT; WNT SIGNALING PATHWAY;

EID: 81555197046     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0031-1284367     Document Type: Article

References (21)

1. Dixon J B. The effect of obesity on health outcomes. Mol Cell Endocrinol: 2010; 316 104 108
2. Kotsis V, Stabouli S, Papakatsika S et al. Mechanisms of obesity-induced hypertension. Hypertens Res: 2010; 33 386 393
3. Krug A W, Ehrhart-Bornstein M. Adrenocortical dysfunction in obesity and the metabolic syndrome. Horm Metab Res: 2008; 40 515 517
4. Goodfriend T L, Egan B M, Kelley D E. Aldosterone in obesity. Endocr Res: 1998; 24 789 796 (Pubitemid 29016481)
5. El-Gharbawy A H, Nadig V S, Kotchen J M et al. Arterial pressure, left ventricular mass, and aldosterone in essential hypertension. Hypertension: 2001; 37 845 850 (Pubitemid 32221602)
6. Goodfriend T L. Aldosterone a hormone of cardiovascular adaptation and maladaptation. J Clin Hypertens (Greenwich): 2006; 8 133 139
7. Krug A W, Ehrhart-Bornstein M. Newly discovered endocrine functions of white adipose tissue: possible relevance in obesity-related diseases. Cell Mol Life Sci: 2005; 62 1359 1362 (Pubitemid 40853823)
8. Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A et al. Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci USA: 2003; 100 14211 14216 (Pubitemid 37499216)
9. Galic S, Oakhill J S, Steinberg G R. Adipose tissue as an endocrine organ. Mol Cell Endocrinol: 2010; 316 129 139
10. Krug A W, Vleugels K, Schinner S et al. Human adipocytes induce an ERK1/2 MAP kinases-mediated upregulation of steroidogenic acute regulatory protein (StAR) and an angiotensin II-sensitization in human adrenocortical cells. Int J Obes (Lond): 2007; 31 1605 1616 (Pubitemid 47482659)
11. Schinner S, Willenberg H S, Krause D et al. Adipocyte-derived products induce the transcription of the StAR promoter and stimulate aldosterone and cortisol secretion from adrenocortical cells through the Wnt-signaling pathway. Int J Obes (Lond): 2007; 31 864 870 (Pubitemid 46663826)
12. Ross S E, Hemati N, Longo K A et al. Inhibition of adipogenesis by Wnt signaling. Science: 2000; 289 950 953 (Pubitemid 30659947)
13. Caron K M, Ikeda Y, Soo S C et al. Characterization of the promoter region of the mouse gene encoding the steroidogenic acute regulatory protein. Mol Endocrinol: 1997; 11 138 147 (Pubitemid 27057427)
14. Hagen T, Sethi J K, Foxwell N et al. Signalling activity of beta-catenin targeted to different subcellular compartments. Biochem J: 2004; 379 471 477 (Pubitemid 38570120)
15. Gummow B M, Winnay J N, Hammer G D. Convergence of Wnt signaling and steroidogenic factor-1 (SF-1) on transcription of the rat inhibin alpha gene. J Biol Chem: 2003; 278 26572 26579 (Pubitemid 36876801)
16. Szekeres M, Turu G, Orient A et al. Mechanisms of angiotensin II-mediated regulation of aldosterone synthase expression in H295R human adrenocortical and rat adrenal glomerulosa cells. Mol Cell Endocrinol: 2009; 302 244 253
17. Kidambi S, Kotchen J M, Grim C E et al. Association of adrenal steroids with hypertension and the metabolic syndrome in blacks. Hypertension: 2007; 49 704 711
18. Nagase M, Yoshida S, Shibata S et al. Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors. J Am Soc Nephrol: 2006; 17 3438 3446 (Pubitemid 44865286)
19. Krug A W, Ehrhart-Bornstein M. Aldosterone and metabolic syndrome: is increased aldosterone in metabolic syndrome patients an additional risk factor? Hypertension: 2008; 51 1252 1258 (Pubitemid 351555932)
20. Schinner S, Ulgen F, Papewalis C et al. Regulation of insulin secretion, glucokinase gene transcription and beta cell proliferation by adipocyte-derived Wnt signalling molecules. Diabetologia: 2008; 51 147 154 (Pubitemid 50002200)
21. Sugawara T, Saito M, Fujimoto S. Sp1 and SF-1 interact and cooperate in the regulation of human steroidogenic acute regulatory protein gene expression. Endocrinology: 2000; 1 2895 2903 (Pubitemid 32250453)